# Commission Implementing Decision (EU) 2018/945 of 22 June 2018 on the communicable diseases and related special health issues to be covered by epidemiological surveillance as well as relevant case definitions (Text with EEA relevance), Division A: Confirmed case

Extent: E+W+S+N.I.

Detection of Zika virus nucleic acid in a clinical specimen;
Detection of Zika virus antigen in a clinical specimen;
Isolation of Zika virus from a clinical specimen;
Detection of Zika specific IgM antibodies in serum, cerebrospinal fluid (CSF) or amniotic fluid.

---
Source: https://www.legislation.gov.uk/eudn/2018/945/annex/II/division/3/division/3.57/division/2/division/A (the official version)
Page: https://openlegislation.uk/eu-decision-2018-945/annex-II/division-3/division-3.57/division-2/division-A
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.